成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 71-00-1 Chemical Structure| 71-00-1
Chemical Structure| 71-00-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 71-00-1

,{[proInfo.pro_purity]}

L-Hisidine is mitochondrial glutamine transport inhibitor, can be used in the biosynthesis of proteins.

Synonyms: Glyoxaline-5-Alanine; NSC 137773; Histidine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Product Citations

Yangfeng Li ; Zhengnan Shen ; Kiira Ratia ; Jiong Zhao ; Fei Huang ; Oleksii Dubrovyskyii , et al.

Abstract: The bromodomain and extra-terminal domain (BET) proteins are epigenetic readers, regulating transcription via two highly homologous tandem bromodomains, BD1 and BD2. Clinical development of nonselective pan-BD BET inhibitors has been challenging, partly due to dose-limiting side effects such as thrombocytopenia. This has prompted the push for domain-selective BET inhibitors to achieve a more favorable therapeutic window. We report a structure-guided drug design campaign that led to the development of a potent BD1-selective BET inhibitor, 33 (XL-126), with a Kd of 8.9 nM and 185-fold BD1/BD2 selectivity. The high selectivity was first assayed by SPR, validated by a secondary time-resolved fluorescence energy transfer assay, and further corroborated by BROMOscan (～57–373 fold selectivity). The cocrystal of 33 with BRD4 BD1 and BD2 demonstrates the source of selectivity: repulsion with His437 and lost binding with the clamp. Notably, the BD1 selectivity of BET inhibitor 33 leads to both the preservation of platelets and potent anti-inflammatory efficacy.

Purchased from AmBeed: ; 56-84-8 ; ; ; ;

Alternative Products

Product Details of H-His-OH

CAS No. :71-00-1
Formula : C6H9N3O2
M.W : 155.15
SMILES Code : N[C@@H](CC1=CNC=N1)C(O)=O
Synonyms :
Glyoxaline-5-Alanine; NSC 137773; Histidine
MDL No. :MFCD00064315

Safety of H-His-OH

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Application In Synthesis of H-His-OH

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 71-00-1 ]

[ 71-00-1 ] Synthesis Path-Downstream   1~9

  • 1
  • [ 71-00-1 ]
  • [ 32926-43-5 ]
  • 2
  • [ 71-00-1 ]
  • D-histidine amide [ No CAS ]
  • [ 32926-43-5 ]
  • 3
  • nickel(II) chloride hexahydrate [ No CAS ]
  • [ 26239-55-4 ]
  • [ 71-00-1 ]
  • Na2[Ni(N-(2-acetamido)iminodiacetato)(histidine)(OH)]*0.5H2O [ No CAS ]
  • 4
  • copper(II) choride dihydrate [ No CAS ]
  • [ 26239-55-4 ]
  • [ 71-00-1 ]
  • Na2[Cu(N-(2-acetamido)iminodiacetato)(histidine)(OH)]*2.5H2O [ No CAS ]
  • 5
  • manganese(II) chloride tetrahydrate [ No CAS ]
  • [ 26239-55-4 ]
  • [ 71-00-1 ]
  • [ 330589-00-9 ]
  • 6
  • cobalt(II) chloride hexahydrate [ No CAS ]
  • [ 26239-55-4 ]
  • [ 71-00-1 ]
  • Na2[Co(N-(2-acetamido)iminodiacetato)(histidine)(OH)]*0.75H2O [ No CAS ]
  • 7
  • [ 636-58-8 ]
  • [ 71-00-1 ]
  • C14H21N5O8S [ No CAS ]
  • 8
  • [ 41360-32-1 ]
  • [ 71-00-1 ]
  • C8H8O5S*C6H9N3O2 [ No CAS ]
YieldReaction ConditionsOperation in experiment
61% In water; at 0 - 45℃; for 4h; (1) Add 15.15 g of L-histidine in 100 ml of water,Add 20g D,L-<strong>[41360-32-1]sulfophenylacetic acid</strong>,The temperature was raised to 45 ° C, the reaction was stirred for 2 hours; the temperature was slowly lowered to 0 ° C to 10 ° C, and the crystallization was stirred for 2 hours;Filtration, washing the filter cake with appropriate amount of cold ethanol to obtain 21 g of D(-)-<strong>[41360-32-1]sulfophenylacetic acid</strong> histidine, the yield is 61.0percent;
  • 9
  • [ 1236199-60-2 ]
  • [ 71-00-1 ]
  • C25H36ClN7O4 [ No CAS ]
  • C25H36ClN7O4 [ No CAS ]
YieldReaction ConditionsOperation in experiment
In aq. buffer; at 37℃;pH 7.3; General procedure: <strong>[1236199-60-2]NL-101</strong> (0.03 g) was incubated with amino acids (0.02 g) and peptides (0.03 g) at 37 oC in a buffer solution, which pH was 5.3,7.3 and 9.3 respectively as the experimental surroundings. The pH of the samples was determined by a pH-meter (FE 20, MettlerToledo). All samples were kept at -20 oC until further analysis. The desalting step of the <strong>[1236199-60-2]NL-101</strong> adducts obtained under theexperimental conditions was not carried out before MS analysis.
 

Related Products

Historical Records

Categories